Krilogy Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $705K | Buy |
3,707
+93
| +3% | +$16K | 0.02% | 510 |
|
|
2026
Q1 | $629K | Buy |
3,614
+76
| +2% | +$13K | 0.02% | 509 |
|
|
2025
Q4 | $622K | Sell |
3,538
-54
| -2% | -$8.77K | 0.02% | 482 |
|
|
2025
Q3 | $569K | Buy |
+3,592
| New | +$490K | 0.02% | 485 |
|
|
2023
Q2 | – | Sell |
-1,815
| Closed | -$234K | – | 283 |
|
|
2023
Q1 | $234K | Sell |
1,815
-3,739
| -67% | -$489K | 0.02% | 366 |
|
|
2022
Q4 | $729K | Buy |
+5,554
| New | +$718K | 0.07% | 201 |
|
|
2022
Q3 | – | Sell |
-1,717
| Closed | -$202K | – | 314 |
|
|
2022
Q2 | $202K | Sell |
1,717
-405
| -19% | -$48.1K | 0.02% | 297 |
|
|
2022
Q1 | $276K | Sell |
2,122
-4
| -0.2% | -$521 | 0.03% | 262 |
|
|
2021
Q4 | $324K | Sell |
2,126
-75
| -3% | -$11.6K | 0.03% | 222 |
|
|
2021
Q3 | $356K | Buy |
2,201
+104
| +5% | +$17.5K | 0.04% | 210 |
|
|
2021
Q2 | $343K | Hold |
2,097
| – | – | 0.03% | 213 |
|
|
2021
Q1 | $316K | Buy |
2,097
+153
| +8% | +$24.3K | 0.03% | 206 |
|
|
2020
Q4 | $295K | Buy |
1,944
+190
| +11% | +$27.2K | 0.04% | 214 |
|
|
2020
Q3 | $237K | Sell |
1,754
-111
| -6% | -$15.1K | 0.03% | 210 |
|
|
2020
Q2 | $255K | Buy |
+1,865
| New | +$238K | 0.04% | 195 |
|
|
2020
Q1 | – | Sell |
-2,343
| Closed | -$282K | – | 209 |
|
|
2019
Q4 | $282K | Buy |
+2,343
| New | +$261K | 0.05% | 170 |
|
|
2019
Q3 | – | Sell |
-1,906
| Closed | -$208K | – | 191 |
|
|
2019
Q2 | $208K | Buy |
1,906
+113
| +6% | +$12K | 0.04% | 166 |
|
|
2019
Q1 | $201K | Buy |
+1,793
| New | +$197K | 0.04% | 168 |
|
|
2018
Q4 | – | Sell |
-2,081
| Closed | -$254K | – | 365 |
|
|
2018
Q3 | $254K | Buy |
+2,081
| New | +$245K | 0.06% | 121 |
|
|
2018
Q2 | – | Sell |
-1,496
| Closed | -$160K | – | 365 |
|
|
2018
Q1 | $160K | Buy |
1,496
+342
| +30% | +$37.9K | 0.04% | 174 |
|
|
2017
Q4 | $123K | Buy |
1,154
+113
| +11% | +$12.1K | 0.03% | 201 |
|
|
2017
Q3 | $116K | Hold |
1,041
| – | – | 0.03% | 218 |
|
|
2017
Q2 | $108K | Sell |
1,041
-3
| -0.3% | -$295 | 0.03% | 204 |
|
|
2017
Q1 | $92K | Hold |
1,044
| – | – | 0.03% | 207 |
|
|
2016
Q4 | $92K | Sell |
1,044
-981
| -48% | -$89.3K | 0.03% | 207 |
|
|
2016
Q3 | $195K | Sell |
2,025
-378
| -16% | -$36K | 0.06% | 124 |
|
|
2016
Q2 | $206K | Buy |
2,403
+2,046
| +573% | +$184K | 0.07% | 119 |
|
|
2016
Q1 | $31K | Buy |
+357
| New | +$31.9K | 0.01% | 323 |
|
|
2015
Q4 | – | Sell |
-144
| Closed | -$15K | – | 494 |
|
|
2015
Q3 | $15K | Buy |
+144
| New | +$17.3K | 0.01% | 343 |
|
Other funds holding IBB
CB
Krilogy Financial's IBB Position: Q2 2026 in Review
Krilogy Financial increased its iShares Biotechnology ETF (IBB) stake by 2.6% in Q2 2026, buying an estimated $16K and bringing the position to 3,707 shares worth $705K. The position accounts for 0.02% of the portfolio, ranked #510.
Krilogy Financial first reported a position in IBB in Q3 2015 and has held it in 29 quarters since. The position peaked at $729K in Q4 2022. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Krilogy Financial held 3,707 shares of iShares Biotechnology ETF worth $705K as of Q2 2026.
- Krilogy Financial bought 93 iShares Biotechnology ETF shares in Q2 2026, an estimated $16K.
- iShares Biotechnology ETF made up 0.02% of Krilogy Financial's portfolio in Q2 2026, its #510 holding.
- Krilogy Financial first reported a position in iShares Biotechnology ETF in Q3 2015 and has held it in 29 quarters since.
- Krilogy Financial's iShares Biotechnology ETF position peaked at $729K in Q4 2022.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.